Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Does drug injection equipment other than syringes transmit hepatitis C?

Sharing drug preparation paraphernalia may not significantly contribute to hepatitis C virus (HCV) transmission among people who inject drugs, according to a study recently published in The Journal

Published
20 September 2017
By
Liz Highleyman
Viral Hepatitis kills more people than HIV, malaria or tuberculosis

According to the Global Burden of Disease study released today, deaths caused by viral hepatitis have surpassed all chronic infectious diseases including HIV/AIDS, malaria and tuberculosis.

Published
18 September 2017
From
World Hepatitis Alliance
High prices of DAAs mean there's been little progress towards achieving WHO target of eliminating HCV by 2030

Only a handful of countries are on course to achieve the World Health Organization (WHO) target of eliminating hepatitis C virus (HCV) as a major

Published
15 September 2017
By
Michael Carter
Injection drug users with HCV in Scotland lack awareness of DAA efficacy

Most people who inject drugs were not aware of currently available, highly effective hepatitis C treatments, according results of a national survey in Scotland presented at the International Symposium on Hepatitis Care in Substance Users. Researchers asked, “What are the chances of hepatitis C being cured with current treatment?” Most participants responded that the chance was low or less than 40%.

Published
12 September 2017
From
Healio
J&J unit ends hepatitis C drug development in crowded market

Janssen Sciences Ireland UC, a unit of Johnson & Johnson, said it would discontinue further development of its hepatitis C research, citing increased availability of a number of effective hepatitis C therapies.

Published
11 September 2017
From
Reuters
The availability of direct-acting antivirals is reducing disparities in the uptake of hepatitis C treatment

An analysis from British Columbia, Canada shows that older people, individuals with HIV co-infection, people with cirrhosis and – to some extent – people who

Published
30 August 2017
By
Roger Pebody
Sharing injection paraphernalia does not lead to HCV transmission

New findings suggest that sharing paraphernalia used to cook and prepare injection drugs does not directly lead to transmission of hepatitis C virus.

Published
24 August 2017
From
Healio
Liver fibrosis speeds up around the menopause in women with HIV and HCV co-infection

Menopause is associated with accelerated liver fibrosis in women with HIV and hepatitis C virus (HCV) co-infection, investigators from the United States report in the online edition of

Published
22 August 2017
By
Michael Carter
People with HIV are at risk for liver fibrosis and steatosis

Metabolic syndrome, type 2 diabetes and obesity are risk factors for the development of liver fibrosis and steatosis (liver fat accumulation) in people living with

Published
21 August 2017
By
Liz Highleyman
Men on PrEP & HIV-positive men are getting hepatitis C during sex—here’s why

Hepatitis C is best known as an infection transmitted by blood, with most new cases of hepatitis C caused by sharing injection drug use equipment. But this dangerous infection, which … Read More →

Published
18 August 2017
From
BETA blog
← First12345...226Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.